Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

PV Audit by Quality: Friends or Foes?

Posted on March 9th, 2017 by in Pharmacovigilance

One of the major ways to measure the health of a Pharmacovigilance (PV) organization is to organize regular audits by experienced Quality Assurance (QA) auditors. During such audits, how open should PV be with the auditors Continue reading “PV Audit by Quality: Friends or Foes?” »

Debates on Pharmacovigilance – What’s new and trending

Posted on March 2nd, 2017 by in Pharmacovigilance

Fleming’s Pharmacovigilance & Risk Management Strategies Forum is always an excellently organized event, attended by industry leaders, policy makers and legislators. Continue reading “Debates on Pharmacovigilance – What’s new and trending” »

5 Most popular Pharmacovigilance blog posts of 2016

Posted on January 26th, 2017 by in Pharmacovigilance

The most-read pharmacovigilance posts of the year really demonstrate the breadth and depth of issues that professionals in this area are dealing with. In these blogs, authors tackled subjects as varied as leadership needs, compliance metrics, the role of scientific literature in identifying adverse events Continue reading “5 Most popular Pharmacovigilance blog posts of 2016” »

Top questions on the minds of QPPV

Posted on December 21st, 2016 by in Pharmacovigilance

The 2016 Pharmacovigilance Days (PHV Day 2016) kicked off in early April 2016 in Berlin, Germany. Afterwards, the tour continued to Amsterdam, London, Copenhagen, Rome and Paris in October and November. With the objective of bringing together safety experts from the pharmaceutical and healthcare industry Continue reading “Top questions on the minds of QPPV” »

  1. 1
  2. 2
  3. 3